DimiCare Biotech
PrivateLast Round
Grant
Nov 17, 2025
Company Overview
DimiCare Biotech operates in Healthcare & Life Sciences and is based in Nice. Its latest recorded funding round was a Grant round in November 2025.
DimiCare Biotech is a biopharmaceutical company developing precision antibiotics to treat multidrug-resistant bacterial infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DimiCare Biotech Comparables
Compare DimiCare Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pylum Biosciences, Inc. | 81% | |
| Glox Therapeutics | 80% | |
| Hsiri Therapeutics | 78% |
For institutional investors. Book with your work email.
DimiCare Biotech Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
DimiCare Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| France 2030 | Grant |
| SATT Sud-Est | Grant |
| Bpifrance | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Monthly visitors increased 182% MoM.
For institutional investors. Book with your work email.
DimiCare Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about DimiCare Biotech's valuation, stock price, and market status.
Is DimiCare Biotech a public or private company?
DimiCare Biotech is a private company.
What is the current stock price of DimiCare Biotech?
DimiCare Biotech is a private company, so its shares have no public market price. Caplight tracks DimiCare Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is DimiCare Biotech worth (valuation)?
Valuation information for DimiCare Biotech is not publicly available.
Can I buy DimiCare Biotech stock?
DimiCare Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was DimiCare Biotech's last funding round?
DimiCare Biotech's most recent funding round was Grant on November 17, 2025.
Who are the main investors in DimiCare Biotech?
Key investors in DimiCare Biotech include France 2030, SATT Sud-Est, Bpifrance.
Will DimiCare Biotech IPO soon?
No public IPO plans have been announced for DimiCare Biotech.
How can I track DimiCare Biotech secondary market activity?
Caplight tracks bids, offers, and trades in DimiCare Biotech's shares on secondary markets.